Browsing Category
Features
927 posts
Antibody Drug Conjugates: Will the Growth Prospects Continue or Not or is the Shine Off?
By
Antibody drug conjugates (ADCs) have been a strong niche in the global oncology drug market. What are the leading commercial ADCs and key pipeline contenders, and will ADCs continue to bode well for CDMOs/CMOs? A look at what lies ahead.